These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 27035065)

  • 1. Effect of ketamine administration, alone and in combination with E-6837, on climbing behavior.
    Briones-Aranda A; Suárez-Santiago JE; Picazo O; Castellanos-Pérez M
    Behav Pharmacol; 2016 Aug; 27(5):485-8. PubMed ID: 27035065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist E-6837 and antagonist SB-271046 of 5-HT6 receptors both reverse the depressive-like effect induced in mice by subchronic ketamine administration.
    Suárez-Santiago JE; Briones-Aranda A; Espinosa-Raya J; Picazo O
    Behav Pharmacol; 2017 Oct; 28(7):582-585. PubMed ID: 28704275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of ketamine-induced social withdrawal in rats: the role of 5-HT7 receptors.
    Hołuj M; Popik P; Nikiforuk A
    Behav Pharmacol; 2015 Dec; 26(8 Spec No):766-75. PubMed ID: 25769091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5-HT6R agonist E-6837 and the antagonist SB-271046 reverse the psychotic-like behaviors induced by ketamine.
    Suárez-Santiago JE; Roldán Roldán G; Picazo Picazo O
    Behav Pharmacol; 2022 Jun; 33(4):249-254. PubMed ID: 35621169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 5-hydroxytryptamine (serotonin) receptor 6 agonist EMD 386088 ameliorates ketamine-induced deficits in attentional set shifting and novel object recognition, but not in the prepulse inhibition in rats.
    Nikiforuk A; Fijał K; Potasiewicz A; Popik P; Kos T
    J Psychopharmacol; 2013 May; 27(5):469-76. PubMed ID: 23479455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional reactivity of the dopaminergic system following acute and chronic ketamine treatments.
    Owolabi AR; Akanmu MA; Ukponmwan OE
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jul; 378(1):117-24. PubMed ID: 18408917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selective mGlu5 receptor antagonist MTEP, similar to NMDA receptor antagonists, induces social isolation in rats.
    Koros E; Rosenbrock H; Birk G; Weiss C; Sams-Dodd F
    Neuropsychopharmacology; 2007 Mar; 32(3):562-76. PubMed ID: 16794564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavior study of ketamine-induced symptoms similar to schizophrenia in mice].
    Liu WL; Bian SZ; Gu ZL; Jiang XG; Guo CY; Zhao YB
    Fa Yi Xue Za Zhi; 2009 Jun; 25(3):172-5. PubMed ID: 19697772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat.
    Kendall I; Slotten HA; Codony X; Burgueño J; Pauwels PJ; Vela JM; Fone KC
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):413-30. PubMed ID: 20405281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain.
    Swartjes M; Morariu A; Niesters M; Aarts L; Dahan A
    Anesthesiology; 2011 Jul; 115(1):165-74. PubMed ID: 21606828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subchronic administration of ketamine decreases the mRNA expression of serine racemase in rat brain.
    Watanabe M; Yoshikawa M; Takeyama K; Hashimoto A; Kobayashi H; Suzuki T
    Tokai J Exp Clin Med; 2010 Dec; 35(4):137-43. PubMed ID: 21319044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia.
    Depoortère R; Bardin L; Auclair AL; Kleven MS; Prinssen E; Colpaert F; Vacher B; Newman-Tancredi A
    Br J Pharmacol; 2007 May; 151(2):253-65. PubMed ID: 17375086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Receptor antagonist of NMDA and animal models of schizophrenia].
    Bian SZ; Zhang J; Liu WL; Sun ZH; Gu ZL; Jiang XG
    Fa Yi Xue Za Zhi; 2009 Dec; 25(6):443-6. PubMed ID: 20225623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of a mechanism responsible for potential antidepressant activity of EMD 386088, a 5-HT6 partial agonist in rats.
    Jastrzębska-Więsek M; Siwek A; Partyka A; Antkiewicz-Michaluk L; Michaluk J; Romańska I; Kołaczkowski M; Wesołowska A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):839-49. PubMed ID: 27106213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine administration during the second postnatal week induces enduring schizophrenia-like behavioral symptoms and reduces parvalbumin expression in the medial prefrontal cortex of adult mice.
    Jeevakumar V; Driskill C; Paine A; Sobhanian M; Vakil H; Morris B; Ramos J; Kroener S
    Behav Brain Res; 2015 Apr; 282():165-75. PubMed ID: 25591475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ST1936, a selective serotonin-6 agonist, on electrical activity of putative mesencephalic dopaminergic neurons in the rat brain.
    Borsini F; Bordi F; Poggi A; Di Matteo V
    J Psychopharmacol; 2015 Jul; 29(7):802-11. PubMed ID: 25735994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral sensitization to ethanol does not result in cross-sensitization to NMDA receptor antagonists.
    Meyer PJ; Phillips TJ
    Psychopharmacology (Berl); 2007 Nov; 195(1):103-15. PubMed ID: 17653696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of esketamine in the treatment of negative symptoms in schizophrenia - A case series.
    Nunes MV; Adelino MPM; Ajub E; Quarantini LC; Lacerda ALT
    Schizophr Res; 2018 Dec; 202():394-396. PubMed ID: 29935883
    [No Abstract]   [Full Text] [Related]  

  • 19. Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia.
    Meltzer HY; Rajagopal L; Huang M; Oyamada Y; Kwon S; Horiguchi M
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2181-94. PubMed ID: 24099265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ketamine alters socially-evoked activity in the amygdala].
    Mihara T; Siegel SJ
    Nihon Yakurigaku Zasshi; 2014 Dec; 144(6):272-6. PubMed ID: 25492362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.